Chemical Compound

1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-; Avodart; Avolve; Dutasteride; GG 745; GI 198745; Veltride; 4-Azaandrost-1-ene-17-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-, (5alpha,17beta)-; (5alpha,17beta)-N-[(2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5-androst-1-ene-17-carboxamide; GI 198745X; GI 206020X; GW 504051X; GW 418079X; GI 246118X; Dutasteride; GW 403358X; GI 246071X; GW 402839X; GW 402836X

CAS Registry Number 164656-23-9
1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-; Avodart; Avolve; Dutasteride; GG 745; GI 198745; Veltride; 4-Azaandrost-1-ene-17-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-, (5alpha,17beta)-; (5alpha,17beta)-N-[(2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5-androst-1-ene-17-carboxamide; GI 198745X; GI 206020X; GW 504051X; GW 418079X; GI 246118X; Dutasteride; GW 403358X; GI 246071X; GW 402839X; GW 402836X 结构式
Primary record

1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-; Avodart; Avolve; Dutasteride; GG 745; GI 198745; Veltride; 4-Azaandrost-1-ene-17-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-, (5alpha,17beta)-; (5alpha,17beta)-N-[(2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5-androst-1-ene-17-carboxamide; GI 198745X; GI 206020X; GW 504051X; GW 418079X; GI 246118X; Dutasteride; GW 403358X; GI 246071X; GW 402839X; GW 402836X

库存
9,891 克
纯度
99.8 %
CAS
164656-23-9

化合物标识与属性

CAS
164656-23-9
PubChem CID
6918296
SMILES
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C
Canonical SMILES
C[C@]12C=CC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)Nc3cc(C(F)(F)F)ccc3C(F)(F)F)CC[C@@H]12

名称与同义词

  • Dutasteride
  • Avodart
  • Avolve
  • 164656-23-9
  • Duastride
  • Duagen
  • veltride
  • Dutasterida
  • dutasteridum
  • Dutasterid
  • Avidart
  • Duprost
  • Avidart;
  • Avodart;
  • Dutagen;
  • Dutasteride [USAN]
  • Dutasteride CRS
  • Avolve;
  • Duagen;
  • Avodart (TN)
  • Dutas;
  • GG-745
  • Avidart (TN)
  • Duprost (TN)
  • Dutagen (TN)
  • Avodart, Dutasteride
  • Avolve (TN)
  • Duagen (TN)
  • Dutas (TN)
  • Dutasteride (Standard)
  • O0J6XJN02I
  • RefChem:57229
  • UNII-O0J6XJN02I
  • DUTASTERIDE [MI]
  • C27H30F6N2O2
  • DUTASTERIDE [INN]
  • DUTASTERIDE [JAN]
  • GI-198745
  • DTXSID8046452
  • GG 745
  • D0A9YA
  • DUTASTERIDE [VANDF]
  • Dutasteride(forbidden drug)
  • AC1OCF98
  • Dutasteride [USAN:INN:BAN]
  • GI 198745
  • SCHEMBL5903
  • JWJOTENAMICLJG-QWBYCMEYSA-N
  • DUTASTERIDE [MART.]
  • GG745
  • MFCD00937869
  • CHEMBL1200969
  • DTXCID6026452
  • DUTASTERIDE [USP-RS]
  • DUTASTERIDE [WHO-DD]
  • Dutasteride (JAN/USP/INN)
  • NSC-740477
  • CHEBI:521033
  • Dutasteride (JAN/USAN/INN)
  • Dutasteride [USAN:INN:JAN]
  • JALYN COMPONENT DUTASTERIDE
  • GTPL7457
  • orb1308434
  • Dutasteride - Bio-X trade mark
  • NSC-759880
  • SCHEMBL29454739
  • Dutasteride, >=98% (HPLC)
  • AOB5568
  • DUTASTERIDE [ORANGE BOOK]
  • G04CB02
  • Dutasteride for system suitability
  • BCPP000248
  • DUTASTERIDE [EP MONOGRAPH]
  • Dutasteride CRS (Y0001598)
  • GI198745
  • GLXC-06659
  • DUTASTERIDE [USP MONOGRAPH]
  • GI-198745X
  • 745, GG
  • BCP02344
  • EX-A1952
  • MSK15349
  • ZINC3932831
  • Tox21_112199
  • BDBM50340481
  • EBC-11281
  • HY-13613R
  • NP3151
  • NSC740477
  • s1202
  • 2-Hydroxy-4-trifluoromethylpyrimidine
  • AKOS015920136
  • AKOS015924431
  • Dutasteride for system suitability CRS
  • MSK15349-100A
  • ACN-046785
  • BCP9000630
  • C27-H30-F6-N2-O2
  • CCG-269904
  • CID6918296
  • CS-1542
  • CS-O-30894
  • DB01126
  • FD22629
  • GS-3565
  • MSK15349-1000A
  • NSC 740477
  • NSC 759880
  • RL02115
  • 4-Bromo-1-isopropylpyridin-2(1H)-one
  • CID:6918296
  • NCGC00164571-01
  • BD164398
  • BR-72895
  • HY-13613
  • SC-08812
  • SID:283537524
  • (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
  • AB1009276
  • J677.498I
  • CAS-164656-23-9
  • D5973
  • ST24026289
  • (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
  • B-2151
  • D03820
  • Dutasteride Solution in Acetonitrile, 100ug/mL
  • EN300-124223
  • J10036
  • 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-
  • AB01274774-01
  • AB01274774_02
  • alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide
  • Dutasteride Solution in Acetonitrile, 1000ug/mL
  • 656D239
  • A810580
  • C108373
  • Q424760
  • (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(2,5-Bis(trifluoromethyl)phenyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
  • BRD-K30373883-001-02-8
  • Dutasteride for System Suitability CRS (Y0001603)
  • (1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
  • D000068538
  • Z1558504346
  • Dutasteride, European Pharmacopoeia (EP) Reference Standard
  • N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
  • 17beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one
  • Dutasteride, United States Pharmacopeia (USP) Reference Standard
  • (1S,2R,7R,10S,11S,14S,15S)-N-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide
  • (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-1H,2H,4aH,4bH,5H,6H,6aH,7H,8H,9H,9aH,9bH,10H,11H,11aH-indeno[5,4-f]quinoline-7-carboxamide
  • (5|A,17|A)-N-{2,5-Bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide
  • 17-beta-N-[2,5-Bis(trifluoromethyl)phenyl]carbamoyl-4-aza-5-alpha-androst-1-en-3-one
  • 17beta-[[2,5-Bis(trifluoromethyl)phenyl]carbamoyl]-4-aza-5alpha-androsta-1-ene-3-one
  • Dutasteride for system suitability, European Pharmacopoeia (EP) Reference Standard
  • N-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
  • (1S,2R,7R,10S,11S,14S,15S)-N-(2,5-bis(trifluoromethyl)phenyl)-2,15-dimethyl-5-oxo-6-azatetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-3-ene-14-carboxamide
  • (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-(2,5-bis(trifluoromethyl)phenyl)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno(5,4-f)quinoline-1-carboxamide
  • (4ar,4bs,6as,7s,9as,9bs,11ar)-n-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1h-indeno[5,4-f]quinoline-7-carboxamide
  • (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
  • (5-alpha,17-beta)-N-{2,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide
  • (5.ALPHA.,17.BETA.)-N-(2,5-BIS(TRIFLUOROMETHYL)PHENYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE
  • (5.alpha.,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide;dutasteride;Avodart;
  • (5|_,17|_)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4- Aza -androst-1-ene-17-carboxamide
  • (5alpha,17beta)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1-ene-17-carboxamide
  • (5alpha,17beta)-N-{2,5-bis(trifluoromethyl)-phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide
  • .ALPHA.,.ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.',.ALPHA.'-HEXAFLUORO-3-OXO-4-AZA-5.ALPHA.-ANDROST-1-ENE-17.BETA.-CARBOXY-2',5'-XYLIDIDE
  • 1646570-98-0
  • 1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-
  • 1h-indeno[5,4-f]quinolina-7-carboxamida, n-[2,5-bis(trifluorometil)fenil]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahidro-4a,6a-dimetil-2-oxo-, (4ar,4bs,6as,7s,9as,9bs,11ar)-
  • 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-; Avodart; Avolve; Dutasteride; GG 745; GI 198745; Veltride; 4-Azaandrost-1-ene-17-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-, (5alpha,17beta)-; (5alpha,17beta)-N-[(2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5-androst-1-ene-17-carboxamide; GI 198745X; GI 206020X; GW 504051X; GW 418079X; GI 246118X; Dutasteride; GW 403358X; GI 246071X; GW 402839X; GW 402836X
  • Avolve,(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide